AMPH vs EG · P/E 12, rev $732.0M vs P/E 17, rev $17.28B
Amphastar P (AMPH) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the AMPH and EG stock pages for the full models.
Not investment advice.